Correlation Between MetaVia and Longboard Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both MetaVia and Longboard Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MetaVia and Longboard Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MetaVia and Longboard Pharmaceuticals, you can compare the effects of market volatilities on MetaVia and Longboard Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MetaVia with a short position of Longboard Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of MetaVia and Longboard Pharmaceuticals.
Diversification Opportunities for MetaVia and Longboard Pharmaceuticals
-0.69 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between MetaVia and Longboard is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding MetaVia and Longboard Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Longboard Pharmaceuticals and MetaVia is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MetaVia are associated (or correlated) with Longboard Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Longboard Pharmaceuticals has no effect on the direction of MetaVia i.e., MetaVia and Longboard Pharmaceuticals go up and down completely randomly.
Pair Corralation between MetaVia and Longboard Pharmaceuticals
Given the investment horizon of 90 days MetaVia is expected to under-perform the Longboard Pharmaceuticals. In addition to that, MetaVia is 85.32 times more volatile than Longboard Pharmaceuticals. It trades about -0.24 of its total potential returns per unit of risk. Longboard Pharmaceuticals is currently generating about 0.65 per unit of volatility. If you would invest 5,977 in Longboard Pharmaceuticals on September 22, 2024 and sell it today you would earn a total of 21.00 from holding Longboard Pharmaceuticals or generate 0.35% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 42.86% |
Values | Daily Returns |
MetaVia vs. Longboard Pharmaceuticals
Performance |
Timeline |
MetaVia |
Longboard Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Good
MetaVia and Longboard Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with MetaVia and Longboard Pharmaceuticals
The main advantage of trading using opposite MetaVia and Longboard Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MetaVia position performs unexpectedly, Longboard Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Longboard Pharmaceuticals will offset losses from the drop in Longboard Pharmaceuticals' long position.MetaVia vs. Dogwood Therapeutics, | MetaVia vs. Eupraxia Pharmaceuticals Common | MetaVia vs. CERo Therapeutics Holdings | MetaVia vs. Opus Genetics, |
Longboard Pharmaceuticals vs. Molecular Partners AG | Longboard Pharmaceuticals vs. MediciNova | Longboard Pharmaceuticals vs. Anebulo Pharmaceuticals | Longboard Pharmaceuticals vs. Champions Oncology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |